Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Heimall

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Journal of Pediatric Hematology/Oncology Nursing|April 18, 2023
A Retrospective Review of Revaccination Patterns in Pediatric Hematopoietic Stem Cell Transplantation RecipientsAnne Wohlschlaeger, Ellen Levy, Raabia N Khan, et al.
Journal of Clinical Immunology|May 26, 2017
Identification of 22q11.2 Deletion Syndrome via Newborn Screening for Severe Combined ImmunodeficiencyJessica C Barry, Terrence Blaine Crowley, Soma Jyonouchi, et al.
Transplantation and Cellular Therapy|July 30, 2023
Quality Improvement Initiative to Improve Time and Adherence to Revaccination after Hematopoietic Cell Transplantation: Implementation of a Revaccination Clinic within the Transplantation ProgramCaitlin Elgarten, Anne Wohlschlaeger, Ellen Levy, et al.
Journal of Clinical Immunology|June 2, 2023
Safety and Efficacy of Hizentra® Following Pediatric Hematopoietic Cell Transplant for Treatment of Primary ImmunodeficienciesNiraj C Patel, Troy Torgerson, Monica S Thakar, et al.
Journal of Clinical Immunology|September 5, 2015
Subcutaneous Immunoglobulin Replacement Therapy with Hizentra® is Safe and Effective in Children Less Than 5 Years of AgeNiraj C Patel, Joel L Gallagher, Hans D Ochs, et al.
Journal of Human Immunity|March 9, 2026
Unmanipulated bone marrow infusion without conditioning can rescue <i>RECQL4</i> <sup>-/-</sup> severe combined immunodeficiencyAlexandra E Grier, Marita Bosticardo, Francesca Pala, et al.
The Journal of Allergy and Clinical Immunology|June 18, 2021
Distinct immune trajectories in patients with chromosome 22q11.2 deletion syndrome and immune-mediated diseasesT Blaine Crowley, Ian M Campbell, Emily J Liebling, et al.
Immunity|November 29, 2011
A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memoryAndrea M Siegel, Jennifer Heimall, Alexandra F Freeman, et al.
Life Science Alliance|August 12, 2024
Neutrophil-avid nanocarrier uptake by STAT3 dominant-negative hyper-IgE syndrome patient neutrophilsKathryn M Rubey, Alexandra Freeman, Alexander R Mukhitov, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 8, 2023
Early intervention in STAT3 dominant negative diseaseZixiao Annie An, Kelli W Williams, Amanda Urban, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Journal of Pediatric Hematology/Oncology Nursing|April 18, 2023
A Retrospective Review of Revaccination Patterns in Pediatric Hematopoietic Stem Cell Transplantation RecipientsAnne Wohlschlaeger, Ellen Levy, Raabia N Khan, et al.
Journal of Clinical Immunology|May 26, 2017
Identification of 22q11.2 Deletion Syndrome via Newborn Screening for Severe Combined ImmunodeficiencyJessica C Barry, Terrence Blaine Crowley, Soma Jyonouchi, et al.
Transplantation and Cellular Therapy|July 30, 2023
Quality Improvement Initiative to Improve Time and Adherence to Revaccination after Hematopoietic Cell Transplantation: Implementation of a Revaccination Clinic within the Transplantation ProgramCaitlin Elgarten, Anne Wohlschlaeger, Ellen Levy, et al.
Journal of Clinical Immunology|June 2, 2023
Safety and Efficacy of Hizentra® Following Pediatric Hematopoietic Cell Transplant for Treatment of Primary ImmunodeficienciesNiraj C Patel, Troy Torgerson, Monica S Thakar, et al.
Journal of Clinical Immunology|September 5, 2015
Subcutaneous Immunoglobulin Replacement Therapy with Hizentra® is Safe and Effective in Children Less Than 5 Years of AgeNiraj C Patel, Joel L Gallagher, Hans D Ochs, et al.
Journal of Human Immunity|March 9, 2026
Unmanipulated bone marrow infusion without conditioning can rescue <i>RECQL4</i> <sup>-/-</sup> severe combined immunodeficiencyAlexandra E Grier, Marita Bosticardo, Francesca Pala, et al.
The Journal of Allergy and Clinical Immunology|June 18, 2021
Distinct immune trajectories in patients with chromosome 22q11.2 deletion syndrome and immune-mediated diseasesT Blaine Crowley, Ian M Campbell, Emily J Liebling, et al.
Immunity|November 29, 2011
A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memoryAndrea M Siegel, Jennifer Heimall, Alexandra F Freeman, et al.
Life Science Alliance|August 12, 2024
Neutrophil-avid nanocarrier uptake by STAT3 dominant-negative hyper-IgE syndrome patient neutrophilsKathryn M Rubey, Alexandra Freeman, Alexander R Mukhitov, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 8, 2023
Early intervention in STAT3 dominant negative diseaseZixiao Annie An, Kelli W Williams, Amanda Urban, et al.
Pageof 9